Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug,
Read MorePfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug,
Read MoreTwo experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly's obesity drugs. Source link
Read MoreTwenty-five years ago, in 1998, researchers in Wisconsin isolated powerful stem cells from human embryos. It was a fundamental breakthrough
Read MoreThe deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which was sparked by
Read MoreDanuglipron, made by Pfizer could offer an advantage as an oral treatment option for weight loss over a frequent injection
Read MoreHe was the only executive to do so before a Senate Health Committee hearing that also included the CEOs of
Read MorePersonal medical devices for conditions such as diabetes and sleep apnea are connecting to the internet, introducing privacy, hacking and
Read MoreAnyone who has more money than they know what to do with eventually tries to cure aging. Google founder Larry
Read MoreDiscovery of Turkish scientist to play key role in treatment of diabetes Hurriyet Daily News Source link
Read More